Sinoway Industrial Co., Ltd.

Octreotide Acetate 83150-76-9 Octreotide Acetate 83150-76-9

Octreotide Acetate 83150-76-9
Related Products
  • Mupirocin 12650-69-0

    Details of MupirocinOther Names: mupirocinMF: C26H44O9Place of Origin: Fujian, China (Mainland)Type: Auxiliaries and Other Medicinal Chemicals, Immune Function AgentsGrade Standard: Medicine GradeBran...

  • Atracurium Besylate 64228-81-5

    Basic information of Atracurium besylate:NameAtracurium besylateAliasCAS NO.64228-81-5 Molecular FormulaC65H82N2O18S2Molecular Weight1243.48Quality StandardCurrent USPPackage Size2kg or 3kg/tin/carton...

  • Ceftiofur Sodium 104010-37-9

    Basic information of Ceftiofur sodium:NameCeftiofur sodiumCAS :104010-37-9Molecular FormulaC19H16N5NaO7S3Molecular Weight545.54Quality StandardPackage SizeFor small quantity:Double plastic bag inside ...

Basic information of Octreotide Acetate 83150-76-9

  • Product name: Octreotide Acetate
  • CAS NO.: 83150-76-9
  • Molecular weight:1019.2393
  • Formula Weight: 1019.24
  • Molecular formula: C49H66N10O10S2
  • Packing: plastic vial (dedicated for peptide packing) or glass vial, quantity according to your detail requirement.
  • Storage: a cool (≤20 degree C) & dry place protected from light, keep package close when not in use.

Usage of Octreotide Acetate 83150-76-9

  • The Food and Drug Administration (FDA) has approved the usage of a salt form of this peptide, octreotide acetate, as an injectable depot formulation for the treatment of acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors (VIPomas).

MORE_DETAIL Octreotide Acetate 83150-76-9

Basic information of Octreotide Acetate 83150-76-9

  • Product name: Octreotide Acetate
  • CAS NO.: 83150-76-9
  • Molecular weight:1019.2393
  • Formula Weight: 1019.24
  • Molecular formula: C49H66N10O10S2
  • Packing: plastic vial (dedicated for peptide packing) or glass vial, quantity according to your detail requirement.
  • Storage: a cool (≤20 degree C) & dry place protected from light, keep package close when not in use.

Usage of Octreotide Acetate 83150-76-9

  • The Food and Drug Administration (FDA) has approved the usage of a salt form of this peptide, octreotide acetate, as an injectable depot formulation for the treatment of acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors (VIPomas).
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//